INDIANAPOLIS (dpa-AFX) – Eli Lilly and Company (LLY) continued its deal-making momentum on June 1, 2026, announcing two new licensing agreements in Asia while also highlighting three infectious-di…
Lilly Continues Its Acquisition Spree, Inks Two Asia Partnerships Today
Source: Finanznachrichten.de
Read Full Story →
